期刊文献+

介入治疗对兔VX_2肝癌MMP-2基因表达的影响

Effect of Interventional Treatment on MMP-2 Gene Expression of Rabbit VX_2 Liver Tumor
原文传递
导出
摘要 目的研究MMP-2在兔VX2肝癌中表达的意义以及介入治疗对其表达的影响。方法建立兔VX2肝癌的动物模型,将实验动物分为介入组和对照组,比较2组的肝功能变化、肿瘤体积增长率,用原位杂交和免疫组化方法研究各组的MMP-2基因及蛋白表达情况。结果对照组的AST和ALT分别高于同一时间段介入组。各组肿瘤随着时间延长体积均增大,但介入治疗后尤其是术后2、3周体积增长减缓,与对照组相比,有显著性差异。原位杂交及免疫组化显示MMP-2mRNA及蛋白表达主要定位于癌细胞胞浆。介入组MMP-2mRNA及蛋白表达的阳性率较对照组明显减少(P<0·05)。转移组MMP-2mRNA及蛋白表达的阳性率较无转移组明显增加(P<0·05)。结论介入治疗能改善肝功能,延缓肿瘤生长,减少转移。MMP-2的高表达预示着高转移潜能。 Objective To study the expression of matrix metalloprotein-2 (MMP-2) and discuss the value ofinterventional treatment in rabbit VX2 liver tumor. Methods 48 rabbit models were randomly divided into study group( n = 24 ) and control group (n = 24 ). The hepatic function,tumor size in two groups were compared. The level of MMP-2 was tested with in situ hybridization and immunohistochemical technology. Results MMP-2 was located in the cytoplasm of tumor cells. The expression of MMP-2 mRNA and protein in control group was signifieantly lower than that of the study group ( P 〈 0. 05 ). In the metastasis group, the level of MMP-2 mRNA and protein was markedly higher than that of no metastasis group( P 〈 0. 05 ). Conclusion The growth of rabbit liver tumors and metastasis could partly be inhibited by interventional treatment. The high expression of MMP-2 indicates the trend of high metastasis.
出处 《临床消化病杂志》 2006年第4期207-209,共3页 Chinese Journal of Clinical Gastroenterology
关键词 VX2肝癌 MMP-2 介入治疗 动物模型 VX2 Liver tumor Rabbit MMP-2 Interventional treetment Animal model
  • 相关文献

参考文献5

  • 1NELSON AR, FINGLETON B, ROTHENBERG ML et al. Matrix metalloproteinases: biologic activity and clinical implications [ J ]. J Clin Oncol, 2000,18 : 1135.
  • 2KAWANO N, OSAWA H, TAKAAKIL et al. Expression of gelatinase A, tissue inhibitor of metalloproteinase-2, matrilysin and trypsin(ogen) in lung neopiasms [ J]. Human Pathol, 1997,28:613.
  • 3KUGLER A. Matrix metalloproteinases and their inhibitors[J]. Anticancer Res, 1999,19 : 1589.
  • 4TALVENSAARI-MATTILA A, Paakko P, Hoyhtya Met al. Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma [ J]. Cancer, 1998,83 : 1153.
  • 5KUYVENHOVE JP, VAN LLOCK B, BLOM E,et al. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patient with various chronic liver diseases and hepatocellular carcinoma [J]. Thromb Haemost, 2003, 89(4):718.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部